Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study.
Perlis, Roy H. MD, MSc *,1; Mehta, Rajesh RPh, MS 2; Edwards, Alison M. MStat 2; Tiwari, Arun MBA 2; Imbens, Guido W. PhD 3
Depression and Anxiety.
35(10):946-952, October 2018.
(Format: HTML, PDF)